Concourse Financial Group Securities’s PRA Health Sciences, Inc. PRAH Stock Holding History

Concourse Financial Group Securities’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-433	Closed	-$72K	–	2523
2021 Q2	$72K	Sell	433 -60	-12%	-$10K	﹤0.01%	1137
2021 Q1	$76K	Buy	493 +45	+10%	+$6.11K	0.01%	1065
2020 Q4	$56K	Buy	448 +405	+942%	+$45.3K	﹤0.01%	1122
2020 Q3	$4K	Sell	43 -1	-2%	-$102	﹤0.01%	1909
2020 Q2	$4K	Buy	44 +13	+42%	+$1.21K	﹤0.01%	1793
2020 Q1	$3K	Buy	31 +4	+15%	+$390	﹤0.01%	1839
2019 Q4	$3K	Hold	27	–	–	﹤0.01%	1842
2019 Q3	$3K	Buy	27 +11	+69%	+$1.09K	﹤0.01%	1496
2019 Q2	$2K	Hold	16	–	–	﹤0.01%	2062
2019 Q1	$1K	Hold	16	–	–	﹤0.01%	2220
2018 Q4	$1K	Buy	+16	New	+$1.62K	﹤0.01%	2085

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Concourse Financial Group Securities's PRAH Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 433 shares — an estimated $72K sold.

Concourse Financial Group Securities first reported a position in PRAH in Q4 2018 and held it in 11 quarters. The position peaked at $76K in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Concourse Financial Group Securities reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Concourse Financial Group Securities sold 433 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $72K.
Concourse Financial Group Securities first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 11 quarters.
Concourse Financial Group Securities's PRA Health Sciences, Inc. position peaked at $76K in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.